Location History:
- Brussels, BE (2007)
- Dilbeek, BE (2008)
Company Filing History:
Years Active: 2007-2008
Title: Stéphane Brézillon: Innovator in G-Protein Coupled Receptor Research
Introduction
Stéphane Brézillon is a notable inventor based in Dilbeek, Belgium. He has made significant contributions to the field of biochemistry, particularly in the study of G-protein coupled receptors. With a total of two patents to his name, his work has implications for both diagnostics and therapeutic applications.
Latest Patents
Stéphane Brézillon's latest patents include innovative methods related to G-protein coupled receptors. The first patent, titled "Methods of identifying modulators of ligand binding to ChemerinR polypeptides," focuses on a G-protein coupled receptor and a novel ligand. This invention provides screening assays for identifying candidate compounds that modulate the activity of the receptor, as well as assays useful for diagnosing and treating diseases related to G-protein coupled receptor signaling dysregulation. The second patent, "Ligand for G-protein coupled receptor GPR43 and uses thereof," identifies short-chain fatty acids as natural ligands for the orphan receptor GPR43. This invention also includes assays for identifying agents that modulate GPR43 ligand binding and signaling activity, along with diagnostic methods and kits that leverage the interaction of GPR43 with short-chain fatty acids.
Career Highlights
Stéphane Brézillon is currently associated with Euroscreen S.A., where he continues to advance research in his field. His work has been instrumental in understanding the mechanisms of G-protein coupled receptors, which are crucial for various physiological processes.
Collaborations
Stéphane has collaborated with notable colleagues such as Emmanuel Le Poul and Michel Detheux. Their combined expertise has contributed to the advancement of research in receptor biology and pharmacology.
Conclusion
Stéphane Brézillon is a prominent figure in the field of G-protein coupled receptor research, with valuable patents that enhance our understanding of receptor-ligand interactions. His contributions have the potential to impact both diagnostics and therapeutic strategies in medicine.